PINS Medical
its implantable deep brain neurostimulation system received NMPA market approval, reported across multiple Chinese outlets in December 2025; the company separately received an innovation green-channel designation for a deep brain stimulator targeting treatment-resistant obsessive-compulsive disorder in September 2025,…
- Country
- China
NMPA approved
Deep brain stimulation
cn
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioelectronic medicine & neuromodulation | regenerative-personalized | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.